申请人:Eli Lilly and Company
                            
                            
                                公开号:US06743794B2
                            
                            
                                公开(公告)日:2004-06-01
                            
                            The present invention further relates to a method of inhibiting MRP1 in a mammal which comprises administering to a mammal in need thereof an effective amount of a compound of formula (I).
                            本发明进一步涉及一种抑制哺乳动物的MRP1的方法,该方法包括向需要该方法的哺乳动物施用公式(I)化合物的有效量。